Michael Tobias Stumpp
Founder bei MOLECULAR PARTNERS AG
Vermögen: 3 Mio $ am 31.03.2024
Profil
Michael Tobias Stumpp is the founder of Molecular Partners AG, which was founded in 2004.
He held the title of Executive Vice President-Projects at the company.
Currently, he is the Managing Director at BASF Mexicana SA de CV since 2013 and the Chief Operating Officer at Molecular Partners, Inc. He has also held former positions as a Principal at Imperial College London from 1995 to 1996, a Principal at the Swiss Federal Institute of Technology from 1993 to 1997, and as a Principal at the Tokyo Institute of Technology.
Dr. Stumpp obtained a doctorate degree from the University of Zurich in 2004.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MOLECULAR PARTNERS AG
2,11% | 31.12.2023 | 767 524 ( 2,11% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Michael Tobias Stumpp
| Unternehmen | Position | Beginn |
|---|---|---|
| MOLECULAR PARTNERS AG | Founder | 01.12.2009 |
BASF Mexicana SA de CV
 BASF Mexicana SA de CV Chemicals: SpecialtyProcess Industries BASF Mexicana SA de CV manufactures and markets chemical, plastic, and crop protection products for agricultural, construction, electronic, and nutrition sector. Its product portfolio includes cement additives, concrete admixtures, chemical solutions, waterproofing systems, sealants, and tile-fixing systems. The company is headquartered in Mexico City. | Chief Executive Officer | 01.09.2013 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Michael Tobias Stumpp
| Unternehmen | Position | Ende |
|---|---|---|
| Swiss Federal Institute of Technology | Corporate Officer/Principal | 01.01.1997 |
| Imperial College London | Corporate Officer/Principal | 01.01.1996 |
| Tokyo Institute of Technology | Corporate Officer/Principal | - |
Ausbildung von Michael Tobias Stumpp
| University of Zurich | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
BASF Mexicana SA de CV
BASF Mexicana SA de CV Chemicals: SpecialtyProcess Industries BASF Mexicana SA de CV manufactures and markets chemical, plastic, and crop protection products for agricultural, construction, electronic, and nutrition sector. Its product portfolio includes cement additives, concrete admixtures, chemical solutions, waterproofing systems, sealants, and tile-fixing systems. The company is headquartered in Mexico City. | Process Industries |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
